Raymond James & Associates Chimerix Inc Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Chimerix Inc stock. As of the latest transaction made, Raymond James & Associates holds 13,200 shares of CMRX stock, worth $112,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,200
Previous 23,200
43.1%
Holding current value
$112,727
Previous $20,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CMRX
# of Institutions
16Shares Held
7.43MCall Options Held
0Put Options Held
0-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Jpmorgan Chase & CO New York, NY1.52MShares$13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY907KShares$7.74 Million0.0% of portfolio
-
Cibra Capital LTD London, X0732KShares$6.25 Million2.13% of portfolio
-
Credit Suisse Ag Zurich, V894KShares$802,7590.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...